 |
|
| Updated Sep. 1, 2010 |
|
||||||||
 |
|
 |
|
 |
|
 |
|
 |
|
||||||||
| ||
| ||
|
Endoscopic Resection Efficacious for Barrett’s Esophagus and Early Esophageal Cancer
ISSUE: JUNE, 2008 Endoscopic therapy has been found to safely and effectively manage high-grade dysplasia in Barrett’s esophagus and early esophageal cancer. read more | ||
|
Issue of Increased All-Cause Mortality With Barrett’s Not Yet Laid To Rest
ISSUE: NOVEMBER, 2007 Does having Barrett’s esophagus put people at risk for cancer incidence or increased mortality, independent of their increased probability of developing or dying from esophageal cancer? And does using jumbo biopsy forceps give gastroenterologists a significantly better chance of picking up dysplasia in patients with BE? read more | ||
|
Tumor-Suppressor Gene May Serve as Biomarker for Response to PDT Therapy in Barrett’s
ISSUE: OCTOBER, 2007 The loss of the tumor-suppressor gene P16 is associated with resistance to treatment in patients with Barrett’s esophagus, a prospective study has confirmed. read more | ||
|
Lawsuits Lead to Excessive Endoscopic Surveillance
ISSUE: SEPTEMBER, 2007 Clinicians with a history of at least one malpractice lawsuit tended to be more aggressive in their use of endoscopic screening and surveillance for esophageal adenocarcinoma, and their decisions seemed strongly influenced by the fear of future legal action. read more | ||
|
Adiponectin May Be Link Between Obesity, Barrett’s
ISSUE: JUNE, 2007 A hormone associated with obesity substantially increases the risk of Barrett’s esophagus, according to study findings. read more | ||
|
Studies Examine Esophageal Capsule Endoscopy, Esophageal Mucosal Pathology
ISSUE: MAY, 2007 Several presentations at last year’s annual meeting of the American College of Gastroenterology provided important new information about Barrett’s esophagus and esophageal mucosal pathology. read more | ||
|
Barrett’s Patients More Likely To Adhere to PPIs
ISSUE: NOVEMBER, 2006 A review of the records of Dutch patients has shown that half of all patients prescribed proton pump inhibitors (PPIs) use them as needed or intermittently, suggesting they may not be reaping the full benefits of drug therapy for their indication. read more | ||
|
Tips for Managing Barrett's With High-Grade Dysplasia
ISSUE: MAY, 2006 Most experts agree that of all patients with Barrett's esophagus (BE), those who have high-grade dysplasia (HGD) are at the highest risk for developing esophageal cancer. read more |
| |
| MOREBREAKTHROUGHS IN BARRETT’S | |
| |
|
• |
Cancer Risk Assessment In Barrett's Reviewed... [1/2006] |
|
• |
Barrett's Patients Who Surf the Net Overestimate T... [1/2005] |
 Breakthroughs in Barrett’s Archives | |
| home | about us | advertise | contact | publications |